IQVIA™ Real-World Insights Bibliography

Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study
Author(s): Jonathan Gladstone 1, Sameer Chhibber 2, Jagdeep Minhas 3, Calum S Neish 3, G Sarah Power 3, Zhiyi Lan 3, Driss Rochdi 4, Jessica Lanthier-Martel 4, Natacha Bastien 4
Affiliations(s): 1Neurology, Cleveland Clinic Canada, Toronto, Ontario, Canada. 2Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. 3Real-world Solutions, IQVIA, Kirkland, Québec, Canada. 4Neuroscience, Novartis Pharmaceuticals Canada Inc., Dorval, Québec, Canada.
Publication(s):  Headache The Journal of Head and Face Pain PMID: 34807454 DOI: 10.1111/head.14218
Document Type(s): Article,
Countries: Canada,
Click here for the abstract
C:
Y:
Health status & patient reported outcomes,
2022
  L:
A:
English
Clinical setting: Primary care, direct to patient research,
  Add to report
 
 
Real-world 12-month Retention on Secukinumab Among Axial Spondyloarthritis Patients within the Canadaian Spondyloarthritis (CanSpA) Research Network
Author(s): Dr. Robert Inman, Dr. Denis Choquette, Dr. Majed Khraishi, Dr. Dafna Gladman, Shamiza Hussein, Drew Neish, Patrick Leclerc
Affiliations(s): Robert Inman (Toronto Western Hospital, Toronto); Denis Choquette (Institut de Rhumatologie de Montréal, Montréal); Majed Khraishi (Department of Medicine, Memorial University of Newfoundland, St. John's); Dafna Gladman (Krembil Research Institute, Toronto Western Hospital, Toronto); Shamiza Hussein (Novartis, Montreal); Drew Neish (IQVIA, Montreal); Patrick Leclerc (Novartis Canada, Montreal)
Publication(s): 
Document Type(s): Poster,
Countries: Canada,
Click here for the abstract
C:
Y:
Clinical practice,
2022
  L:
A:
English
Clinical setting: hospital,
  Add to report
 
 
Concomitant Medication Use in the Treatment Journey of Pulmonary Arterial Hypertension Patients: A Canadian Retrospective Claims Analysis
Author(s): Essam Ibrahim1, Assem Al-Akabawi1, Moses Dawodu1, Juejing Ling2, Irene Wang2, Brad Millson3
Affiliations(s): 1Janssen Canada Inc, Toronto, ON, Canada; 2IQVIA Solutions Canada Inc., Mississauga, ON, Canada; 3IQVIA Solutions Canada Inc., Kanata, ON, Canada
Publication(s): 
Document Type(s): Poster,
Countries: Canada,
C:
Y:
Endocrinology,
2022
  L:
A:
English
Clinical setting: hospital, Clinical setting: Primary care, direct to patient research, Observational study,
  Add to report
 
 
Real-World Drug Retention and Initiation of Combination Drug Therapy for Patients with Pulmonary Arterial Hypertension in Canada: A Retrospective Prescription Claims Database Study
Author(s): Essam Ibrahim1, Assem Al-Akabawi1, Moses Dawodu1, Juejing Ling2, Jillian Murray2, Brad Millson3
Affiliations(s): 1Janssen Canada Inc, Toronto, ON, Canada; 2IQVIA Solutions Canada Inc., Mississauga, ON, Canada; 3IQVIA Solutions Canada Inc., Kanata, ON, Canada
Publication(s):  IQVIA Canadian Private Drug Plan (PDP) databases
Document Type(s): Poster,
Countries: Canada,
C:
Y:

2022
  L:
A:
English
direct to patient research,
  Add to report
 
 
A real-world, observational study of erenumab for migraine prevention in Canadian patients
Author(s): Werner J Becker 1, Sian Spacey 2, Elizabeth Leroux 3, Rose Giammarco 4, Jonathan Gladstone 5, Suzanne Christie 6, Arash Akaberi 7, G Sarah Power 8, Jagdeep K Minhas 9, Johanna Mancini 7, Driss Rochdi 10, Ayca Filiz 10, Natacha Bastien 10
Affiliations(s): 1Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. 2Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada. 3Brunswick Medical Center, Montreal, Quebec, Canada. 4Hamilton Headache Clinic, Hamilton, Ontario, Canada. 5Gladstone Headache Clinic, Toronto, Ontario, Canada. 6Ottawa Headache Centre Inc., Ottawa, Ontario, Canada. 7IQVIA Solutions Canada Inc., Montreal, Quebec, Canada. 8IQVIA Solutions Canada Inc., Mississauga, Ontario, Canada. 9IQVIA Solutions Canada Inc., Ottawa, Ontario, Canada. 10Novartis Canada, Dorval, Quebec, Canada.
Publication(s):  Headache. 2022 Apr;62(4):522-529. doi: 10.1111/head.14291. Epub 2022 Apr 10. PMID: 35403223.
Document Type(s): Article,
Countries: Canada,
Click here for the abstract
C:
Y:
Neurological disorders,
2022
  L:
A:
English
Observational study,
  Add to report
 
 
Characterisation of Pulmonary Arterial Hypertension (PAH) Patients Initiating a New PAH Specific Therapy in the Context of Age: Insights from EXPOSURE
Author(s): P. Escribano (1), S. Gaine (2), P. Biedermann (3), A. Muller (3), M. Valge (4), T. Lange (5), S. Söderberg (6)
Affiliations(s): 1 Pulmonary Hypertension Unit, Cardiology Department, CIBERCV, Hospital 12 de Octubre, Madrid, Spain 2 National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland 3 Actelion Pharmaceuticals Ltd, Allschwil, Switzerland 4 StatFinn Estonia OÃœ, Tartu, Estonia (now IQVIA) 5 University Medical Center Regensburg, Regensburg, Germany 6 Department of Public Health and Clinical Medicine, Cardiology and Heart Centre, UmeÃ¥ University, UmeÃ¥, Sweden
Publication(s):  JO - The Journal of Heart and Lung Transplantation VL - 40 IS - 4, Supplement SP - S109 PY - 2021 DA - 2021/04/01/ SN - 1053-2498
Document Type(s): Abstract,
Countries: Canada, Europe,
Click here for the abstract
C:
Y:
Cardiovascular disease,
2021
  L:
A:
English
Epidemiological study, Observational study,
  Add to report
 
 
Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus and Influenza Related Hospitalizations in Adults – A Global Study During the 2017-2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study)
Author(s): Ann R Falsey, Edward E Walsh, Stacey House, Yannick Vandenijck, Xiaohui Ren, Sofia Keim, Diye Kang, Pascale Peeters, James Witek, Gabriela Ispas
Affiliations(s): University Of Rochester School Of Medicine and Rochester Regional Health, Rochester, NY, United States; Washington University School of Medicine, St Louis, MO, United States; Janssen Infectious Diseases, Beerse, Belgium; IQVIA Real-World Solutions, Courbevoie, France; Janssen Research & Development, LLC, Titusville, NJ, United States
Publication(s): 
Document Type(s): Article,
Countries: Argentina, Australia, Brazil, Canada, France, Germany, Japan, Korea, Malaysia, Mexico, South Africa, USA,
Click here for the abstract
C:
Y:
Infectious disease,
2021
  L:
A:
English
Burden of illness, Clinical setting: hospital, Epidemiological study, Observational study, Patient questionnaire, Prospective study,
  Add to report
 
 
Understanding the COVID Impact on Healthcare System in Canada
Author(s): Juejing Ling, Scott Shi, Marc Lapierre, HuijuanYang, Brad Millson
Affiliations(s): Juejing Ling IQVIA, Scott Shi IQVIA, Marc Lapierre IQVIA, HuijuanYang IQVIA, Brad Millson IQVIA
Publication(s):  2021 CADTH Symposium Confrence, November 2, 3 and 4, 2021
Document Type(s): Poster,
Countries: Canada,
C:
Y:
COVID-19,
2021
  L:
A:
English
Clinical setting: Primary care, Economic evaluation,
  Add to report
 
 
Prescribing patterns among in-person vs virtual primary care visits pre-and post-COVID-19 in Ontario, Canada
Author(s): Muratov S, Neish D, Ellis K, Wang I, Yang H, Bhattacharjee P, Barot P, Kukaswadia A
Affiliations(s): Muratov S, Neish D, Ellis K, Wang I, Yang H, Bhattacharjee P, Barot P, Kukaswadia A - all IQVIA authors
Publication(s):  CAPT 2021 Confrence, October 25-27, 2021
Document Type(s): Poster,
Countries: Canada,
C:
Y:
COVID-19,
2021
  L:
A:
English
Clinical setting: Primary care, Public Health, Survey research,
  Add to report
 
 
Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study
Author(s): Jonathan Gladstone 1, Sameer Chhibber 2, Jagdeep Minhas 3, Calum S Neish 3, G Sarah Power 3, Zhiyi Lan 3, Driss Rochdi 4, Jessica Lanthier-Martel 4, Natacha Bastien 4
Affiliations(s): 1Neurology, Cleveland Clinic Canada, Toronto, Ontario, Canada. 2Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. 3Real-world Solutions, IQVIA, Kirkland, Québec, Canada. 4Neuroscience, Novartis Pharmaceuticals Canada Inc., Dorval, Québec, Canada.
Publication(s):  PMID: 34807454 DOI: 10.1111/head.14218
Document Type(s): Article, Book chapter,
Countries: Canada,
Click here for the abstract
C:
Y:
Miscellaneous,
2021
  L:
A:
English
direct to patient research, Retrospective cohort analysis,
  Add to report
 
 
 1 of 13 Next Page Last Page